MYLK and neoplasm: Here we show that PI3Kγ activates a high molecular weight form of myosin light chain kinase, MLCK210, leading to myosin-dependent activation of Rap1 GTP loading and integrin α4β1 conformational changes that promote tumor inflammation and progression.